Klinique Medical Clinic Future Growth
Future criteria checks 4/6
Klinique Medical Clinic is forecast to grow earnings and revenue by 17.8% and 20.5% per annum respectively. EPS is expected to grow by 17.8% per annum. Return on equity is forecast to be 21.6% in 3 years.
Key information
17.8%
Earnings growth rate
17.8%
EPS growth rate
| Healthcare earnings growth | 10.2% |
| Revenue growth rate | 20.5% |
| Future return on equity | 21.6% |
| Analyst coverage | Low |
| Last updated | 19 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4,355 | 441 | 273 | 748 | 2 |
| 12/31/2025 | 3,704 | 383 | 252 | 682 | 3 |
| 12/31/2024 | 2,938 | 305 | 256 | 532 | 1 |
| 9/30/2024 | 2,784 | 301 | -45 | 490 | N/A |
| 6/30/2024 | 2,626 | 298 | -76 | 404 | N/A |
| 3/31/2024 | 2,464 | 295 | -51 | 388 | N/A |
| 12/31/2023 | 2,285 | 289 | 19 | 386 | N/A |
| 9/30/2023 | 2,132 | 271 | 119 | 490 | N/A |
| 6/30/2023 | 1,973 | 245 | 106 | 440 | N/A |
| 3/31/2023 | 1,816 | 229 | 194 | 451 | N/A |
| 12/31/2022 | 1,639 | 205 | 181 | 408 | N/A |
| 9/30/2022 | 1,487 | 199 | 161 | 333 | N/A |
| 6/30/2022 | 1,213 | 169 | 141 | 284 | N/A |
| 3/31/2022 | 1,056 | 145 | 128 | 242 | N/A |
| 12/31/2021 | 950 | 129 | 165 | 239 | N/A |
| 12/31/2020 | 1,001 | 145 | 100 | 248 | N/A |
| 12/31/2016 | 651 | 33 | N/A | 66 | N/A |
| 12/31/2015 | 650 | 64 | N/A | 101 | N/A |
| 12/31/2014 | 443 | -32 | N/A | 107 | N/A |
| 12/31/2013 | 217 | -12 | N/A | 47 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KLINIQ-R's forecast earnings growth (17.8% per year) is above the savings rate (2%).
Earnings vs Market: KLINIQ-R's earnings (17.8% per year) are forecast to grow slower than the TH market (17.9% per year).
High Growth Earnings: KLINIQ-R's earnings are forecast to grow, but not significantly.
Revenue vs Market: KLINIQ-R's revenue (20.5% per year) is forecast to grow faster than the TH market (6.9% per year).
High Growth Revenue: KLINIQ-R's revenue (20.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: KLINIQ-R's Return on Equity is forecast to be high in 3 years time (21.6%)